What happens when biomedical startups get a head start with built-in infrastructure, regulatory guidance, and hands-on knowledge? In this episode, Kurt Gielen, Chief Business Officer at Medace, shares how they’ve built a globally unique model that accelerates early-stage innovation in the life sciences.

We dive into the origins of Medace, its one-stop-shop approach for clinical trial readiness, and how it's helping founders avoid common pitfalls by embedding quality and compliance from day one. If you're building in healthtech, this is a blueprint you’ll want to hear.